Imaging genetics has become a highly popular approach in the field of schizophrenia research. A frequently reported finding is that effects from common genetic variation are associated with a schizophrenia-related structural endophenotype. Genetic contributions to a structural endophenotype may be easier to delineate, when referring to biological rather than diagnostic criteria. We used coordinate-based meta-analyses, namely the anatomical likelihood estimation (ALE) algorithm on 30 schizophrenia-related imaging genetics studies, representing 44 single-nucleotide polymorphisms at 26 gene loci investigated in 4682 subjects. To test whether analyses based on biological information would improve the convergence of results, gene ontology (GO) terms were used to group the findings from the published studies. We did not find any significant results for the main contrast. However, our analysis enrolling studies on genotype × diagnosis interaction yielded two clusters in the left temporal lobe and the medial orbitofrontal cortex. All other subanalyses did not yield any significant results. To gain insight into possible biological relationships between the genes implicated by these clusters, we mapped five of them to GO terms of the category "biological process" (AKT1, CNNM2, DISC1, DTNBP1, VAV3), then five to "cellular component" terms (AKT1, CNNM2, DISC1, DTNBP1, VAV3), and three to "molecular function" terms (AKT1, VAV3, ZNF804A). A subsequent cluster analysis identified representative, non-redundant subsets of semantically similar terms that aided a further interpretation. We regard this approach as a new option to systematically explore the richness of the literature in imaging genetics.
Introduction
Since Egan et al. (2001) published their iconic paper on differential working memory-related neural activations due to the Val158Met polymorphism in the dopamine Hildegard Janouschek and Claudia R. Eickhoff have contributed equally.
Electronic supplementary material
The online version of this article (https ://doi.org/10.1007/s0042 9-018-1670-9) contains supplementary material, which is available to authorized users.
3
catabolism-related COMT gene (rs4680), the field of imaging genetics has become a highly popular approach in schizophrenia research. Motivated by the hypothesis that gene variants exert stronger effects on a neuroimaging endophenotype than on a behavioral phenotype (Mier et al. 2010) , the characterization of functional and structural neuroimaging correlates associated with genetic variation has been pursued with the intention to bridge the gap between molecular genetics and neural system level findings.
Classical approaches with candidate genes, however, have met important obstacles. Most common variants associated with psychiatric disorders such as schizophrenia only exhibit low effect sizes regarding the manifestation of the disorder (Schizophrenia Working Group of the Psychiatric Genomics Consortium 2014). Thus, imaging genetics studies are necessarily based on the hypothesis that effects on a neuroimaging endophenotype are extensively greater than on a behavioral level to get reliably detected with the usual sample sizes of a few hundred individuals (Mier et al. 2010 ). However, if this assumption does not hold true, the option to identify effects on brain structure and/or function associated with these genetic variants by imaging genetics approaches will be severely hampered. Meta-analyses should be able to identify brain regions, whose structure or function is consistently associated with a particular genetic variant across individual studies. However, a recent coordinate-based metaanalysis on working memory-related neural activations and the COMT rs4680 single-nucleotide polymorphism (SNP)-the most extensively studied gene-brain function association today-did not retrieve significant results (Nickl-Jockschat et al. 2015a) . Although a variety of confounds might have influenced this negative finding, it should be emphasized that a meta-analytic validation of the imaging genetics concept still is lacking, at least at a whole-brain level.
Given these limitations, a quantitative review of the existing literature on imaging genetics with coordinatebased meta-analyses (Eickhoff et al. 2009 has the potential to overcome the shortcomings of an individual study. This type of meta-analysis determines whether the reported maxima spatially converge above chance across individual studies. Thus, it provides a tool to capitalize on the wealth of the published literature and opens up new opportunities to systematically explore the existing data. In the context of imaging genetics, this concept can be applied in at least two meaningful ways: first, it can serve to investigate whether the effects of one given gene variant on brain structure and/or function spatially converge in distinct brain regions above chance. This approach has been demonstrated previously by our lab in a study on neural activations related to working memory tasks and the COMT Val158Met (=rs4640) polymorphism (Nickl-Jockschat et al. 2015a, b) . Second, it can be used to explore, whether different gene variants converge with their effects in the same brain regions above chance. In other words, if there is a claim in the literature that different gene variants all exert their effects, e.g., in the frontal lobe, coordinate-based meta-analysis is a powerful tool to determine, whether this claim actually holds true.
This latter approach has the great advantage that it is able to corroborate the contributions of different gene variants to a given endophenotype. In contrast to genome-wide association studies (GWAS) that use a structural (or functional) endophenotype for gene discovery (Thompson et al. 2014) , the actually presented approach comes with the disadvantage that it is certainly limited to-and, therefore, biased accordingly-the gene variants, on which studies have already been conducted. On the other hand, it goes along with three comparative advantages: it allows the pooling over large cohorts largely without any additional costs. It seems also more sensitive in comparison to genome-wide approaches, since the number of genes is already narrowed down by different a priori hypotheses. Finally, this approach also allows exploratory analyses, whether, e.g., a grouping of studies based on biological information of the genes or on diagnostic criteria is more likely to yield significant results.
Imaging genetic studies on risk gene variants that have been reported to be associated with a schizophrenia-related brain endophenotype are good candidates in this regard. One of the most outstanding findings that was reported across many original studies is that structural changes associated with a putative risk allele were predominantly found in regions associated with the disorder, irrespective of the nearest gene to which the variant maps (Barnes et al. 2012; Cassidy et al. 2014; Donohoe et al. 2011; Kempf et al. 2008; Nenadic et al. 2012) . These susceptibility regions seemed to be affected by schizophrenia risk variants, regardless of whether schizophrenia patients or healthy controls were examined (Donohoe et al. 2011; Ho et al. 2006; Nenadic et al. 2015; Ohi et al. 2012) . These reports seem even more striking when taken into consideration that some of the examined gene variants that were initially studied as schizophrenia susceptibility candidates were not confirmed in GWAS or even with substantial evidence against a role in the pathogenesis of the disorder (e.g., DISC1; Mathieson et al. 2012 and COMT; Okochi et al. 2009 ). Consequently, gene variants might contribute to a neuroanatomical endophenotype, while they are not involved in the pathogenesis of the disorder itself (Franke et al. 2016) . We, therefore, decided to conduct a meta-analysis that pools over all available studies that claim to study risk genes associated with a structural schizophrenia-related endophenotype.
Coordinate-based meta-analysis is a powerful tool to determine, whether this notion of a clustering in schizophrenia susceptibility regions can be objectively reproduced by synthesizing the results of the individual studies. It has also the potential to explore whether potentially convergent findings are largely driven by schizophrenia variants identified by GWAS or whether there is little overlap.
Moreover, coordinate-based meta-analysis of structural imaging genetic studies could also provide important hints to another central riddle of schizophrenia. The currently used diagnostic classification systems define schizophrenia as a syndrome, with its diagnosis based on a constellation of clinical symptoms, rather than a common pathomechanism (American Psychiatric Association 2013; World Health Organization 2010). Thus, the concept of schizophrenia might serve as an umbrella, under which various etiologically and pathophysiologically diverse disease entities are subsumed (Tandon et al. 2013) . This notion has led to the claim that schizophrenia is not a valid concept for biological research and should be "deconstructed" (Gur et al. 2007) or even completely abolished also for clinical use. Congruent with those ideas, schizophrenia patients usually exhibit high interindividual variance with regard to, e.g., brain structure changes, reflecting a higher heterogeneity amongst the patients than amongst healthy controls. This heterogeneity in the patient group has been explained due to different patterns of genetic lesions in individual patients that, in turn, lead to different endophenotypes, which are phenotypically, however, all assumed under the diagnosis of schizophrenia (Gur et al. 2007 ). Given these considerations, if endophenotypes can serve as markers for increased vulnerability also in healthy risk genotype carriers, these endophenotypes might be easier to delineate, when recurring to biological criteria rather than diagnosis.
The use of biological criteria should, therefore, help to reduce heterogeneity of findings. Following this line of thought, pooling meta-analytically over data sets of structural imaging genetics studies can be expected to reduce biological heterogeneity more and, therefore, yield more likely significant results, when studies are grouped by biological criteria, i.e., according to pathways or biological functions of the studied genes, than by diagnostic criteria, e.g., whether patients or healthy controls were enrolled in an actual study. This approach is based on the assumption that variants in genes that are involved in common biological processes are more likely to cause structural changes in identical brain regions than those variants that are not part of a joint biological mechanism. While the explanatory power of a meta-analysis on classical imaging genetics studies-unlike GWAS-based analyses of original neuroimaging data sets-is certainly limited to the set of gene variants that were reported in the respective publications, an increased homogeneity of findings due to the application of biological or diagnostic criteria, nevertheless, has the potential to add important clues to this central puzzle of schizophrenia. Coordinate-based meta-analysis, therefore, provides a powerful tool to quantitatively test such hypotheses based on the spatial convergence of imaging genetic findings capitalizing on the richness of the existing literature.
Methods

Literature search and selection
We performed a literature search for structural magnetic resonance imaging (sMRI) studies using voxel-based morphometry (VBM) to determine gene × structure interactions of genetic variants that the authors suspected to cause a schizophrenia-relevant endophenotype, using Pubmed (http://www.pubme d.org, search strings in Supplementary . Additional papers were then identified through reference tracing from the retrieved articles as well as from qualitative reviews of the literature. To avoid an early selection bias due to overtly restrictive inclusion criteria, we decided to include all studies that claimed to investigate genetic markers that might contribute to a schizophrenia-relevant endophenotype. In a subsequent step, the respective gene variants were classified according to their evidence for an association with the disorder itself (see Table 1 ).
The inclusion criteria were as follows: (1) sMRI studies listed on Pubmed or Google Scholar that have been published until June 3rd, 2015, (2) original peer-reviewed studies, (3) whole-brain assessment not restricting analysis or inference to a priori regions of interest, (4) studies reporting contrasts due to genotypes of susceptibility gene variants that might contribute to a schizophrenia-relevant endophenotype, if studies reported also contrasts due to genotypes of susceptibility markers for other disorders, only those coordinates were included in the analysis that were described as relevant for schizophrenia, (5) complete reporting of peak coordinates of all clusters in stereotactic space (Talairach/ MNI), and (6) bidirectional analysis of contrasts (i.e., analysis of both GM increases and decreases). As structural changes should converge in certain brain regions, namely those associated with the disorder, regardless of the actual SNP (cf. Barnes et al. 2012; Cassidy et al. 2014; Donohoe et al. 2011; Kempf et al. 2008; Nenadic et al. 2012 ), we did not define a minimum set of studies on any particular SNP but rather included all findings on the effects of risk alleles on brain structure.
We extracted all genes that were assigned to common polymorphisms by the original publications. Symbols of the reported genes were checked if they match to the latest approved definition by the Human Gene Nomenclature Committee (HGNC; http://www.genen ames.org) (Gray Table 2 ). Our search identified a total of 358 articles in Pubmed or Google Scholar. 328 studies had to be excluded due to one of the following reasons: no whole-brain data were available, no stereotactic coordinates available, no direct linear contrasts according to genotype, or studies contained solely data derived from ROI-based analyses. A total of 30 studies were included in the meta-analysis that enroll 4682 subjects (3081 healthy controls, 1356 schizophrenia patients, 52 patients with bipolar disorder, 37 patients with OCD, a sample consisting of 65 high-risk individuals with or without symptoms, 43 SNPs and one length polymorphism located at 26 gene loci) ( Table 1 ).
All coordinates were extracted and annotated with the following information:
(1) The study that reported the coordinate.
(2) The SNP that was actually studied in the experiment that yielded the coordinate. (3) The gene that this SNP maps to.
Based on large-scale assessment of the ALE algorithm and current recommendations (Eickhoff et al. 2016; Müller et al. 2018 ), we required a minimum of n ≥ 15 experiments for all contrasts realized in this study.
Categorization of studies according to the original contrasts
The original contrasts in all identified studies were then screened and the category of each analysis that yielded the VBM coordinates was extracted (e.g., "genotype effect", if the analysis was based on a linear contrast between genotypes or "genotype × age interaction", if such an interaction analysis yielded the respective coordinates). In particular, we coded the experiments to be included in the meta-analysis by the following categories: "genotype effects", "gene × diagnosis interactions", "gene × gene interactions", "gender × genotype interactions" and "age × genotype interactions". In addition, we recorded the following information per experiment: study name (author, year), marker name (if more than one marker was reported, experiments were tagged by all markers that were studied in the respective contrast), and gene symbol. We, then, examined, which category yielded a sufficient number of experiments (n ≥ 15) and noted that this was only the case for two categories, namely genotype effects and genotype × diagnosis interactions. It should be noted that the latter analysis assessed whether coordinates reported in the original papers for genotype × diagnosis interactions showed a significant spatial convergence across different experiments. A total of 30 studies met the inclusion criteria. This table summarizes these studies including the studied SNPs, the genes mapping next to these SNPs, the original analyses and sample characteristics in the respective original studies
Categorization of studies according to gene ontology
The functional categories of gene ontology (GO) describe gene products with regard to their associated "biological processes", "cellular components", and "molecular functions", in a species-independent manner. The selected gene symbols were mapped to GO terms and tested for an enrichment of gene sets (GSEA) in the three functional categories using a tool from the STRING database version 10.0 (http://strin g-db.org/) with the configurations "genome background", "specific", "IEA" (inferred from electronic annotation), and "Bonferroni" (correction for multiple comparisons) (Szklarczyk et al. 2015) . The GSEA was performed for each category separately. The top 5 enriched GO terms of each category were included in the subsequent meta-analysis for which the underlying genetic markers provided a sufficient number of VBM experiments (n ≥ 15). These were the terms "axon", "cellular projection", "neuron part" and "neuron projection".
Condensation of gene ontology terms
To sum up and visualize the biological information provided by the identified GO terms, the tool REduce + VIsualize Gene Ontology (REVIGO; http://revig o.irb.hr) was used (Supek et al. 2011 ). The procedure is based on the concept of semantic similarity measures (Pesquita et al. 2009 ). For summarization of the terms, REVIGO performs a clustering analysis that is similar to hierarchical clustering methods such as the neighbor joining approach. REVIGO prioritizes terms with higher a "uniqueness" value-the negative of average similarity of a term to all other terms. REVIGO was run under the configurations "allowed similarity: medium (C value = 0.7)", "GO term size: Homo sapiens", and "semantic similarity measure: Sim-Rel". REVIGO used GO annotations from the July 2015 monthly release by the GO consortium (go_201507-termdb.obo-xml.gz, GO consortium) and UniProt-to-GO mapping data from the EBI GOA project, downloaded at the 27th July 2015 (gene_association.goa_ uniprot.gz). The terms that remained in the table after the clustering procedure are the cluster representatives; no two representatives will be more similar than the cutoff value C. The procedures were done for each functional category separately.
Activation likelihood estimation meta-analysis
The meta-analyses were conducted using a revised version (Eickhoff et al. 2009 of the activation likelihood estimation (ALE) approach for coordinate-based meta-analysis of neuroimaging results (Laird et al. 2005; Turkeltaub et al. 2002 Turkeltaub et al. , 2012 . ALE is based upon the approach to treat the reported foci as centers of 3D Gaussian probability distributions reflecting the spatial uncertainty associated with each reported set of coordinates (Eickhoff et al. 2009; Turkeltaub et al. 2012) and to determine brain regions showing a convergence of findings across studies which is higher than expected under a spatially random spatial association. All reported foci for a given experiment were combined for each voxel to produce a modeled activation map (MA map; Turkeltaub et al. 2002) . ALE scores describing the convergence of coordinates for each location were then calculated via the union of individual MA maps. To distinguish areas where the convergence between studies was greater than it would be expected by chance (i.e., to separate true convergence from noise) ALE scores were compared to a nonlinear histogram integration based on the frequency of distinct MA values . For statistical inference, the ensuing statistical parametric maps were then thresholded at p < 0.05 (cluster-level FWE, corrected for multiple comparisons, cluster-forming threshold at voxel level p < 0.001) . Given the frequent claims regarding the effects of different gene variants on the same brain regions, we decided to conduct a first meta-analysis pooling across all studies that declared to report on schizophrenia susceptibility variants. In a subsequent step, we aimed to investigate, whether significant effects were detectable in subsamples defined by diagnostic status. We, thus, conducted meta-analyses for the following subgroups: healthy controls, schizophrenia patients, genotype × diagnosis interaction. Resulting clusters were analyzed to delineate which coordinates contributed to a resulting cluster and the tagged information was extracted (see "Categorization of studies according to gene ontology"). We finally pooled over studies using biological information ("Categorization of studies according to gene ontology").
For all clusters indicating significant convergence across SNP-brain structure association studies as revealed by the meta-analyses, we analyzed which experiments actually contributed to these findings. Based on our annotations (cf. "Literature search and selection"), we analyzed which SNPs were studied in the contrasts that yielded the respective coordinates contributing to a significant finding in the ALE analysis, and which genes these SNPs mapped to.
We used the Anatomy Toolbox (Eickhoff et al. 2005 (Eickhoff et al. , 2006 (Eickhoff et al. , 2007 to refer all obtained clusters to compare the localization of the significant effects to histological areas.
Conjunction analysis
Brain structure changes have been robustly characterized in schizophrenia patients. To relate our findings to a neuroanatomical endophenotype of schizophrenia, we carried out a conjunction analysis between the clusters of our actual meta-analysis and the results of a previous meta-analysis of our lab on structural changes in schizophrenia (NicklJockschat et al. 2011 ). In detail, we computed the intersection of the thresholded maps using FSLmaths (Jenkinson et al. 2012) .
Results
Main analysis pooling over all studies
We did not find any significant results in the meta-analysis for the main contrast that pooled the data from all 30 studies (best p value = 0.3).
Analyses according to the original contrasts
Our meta-analysis on gene × diagnosis interactions yielded two significant clusters, the larger one in the left middle temporal gyrus (allocation by cytoarchitectonic probabilistic mapping: TE 1.0, extending into TE 1.2; − 51, − 19, 1, k = 98) and a slightly smaller one in the right gyrus rectus close to the midline (mainly located in area Fo2; 9, 13, − 23, k = 86). Coordinates that contributed to the cluster in the left middle temporal gyrus stemmed from contrasts of studies investigating genetic variants in the following genes: ZNF804A (rs1344706), CNNM2 (rs7914558), AKT1 (rs2494732) and DTNBP1 (rs1011313). For the cluster in the right supramarginal gyrus, we found coordinates contributing the investigated variants in the following genes: VAV3 (rs1410403), CCDC68 (rs12966547) and DISC1 (rs821597) (Fig. 1, see Table 2 for the studies that were analyzed within this contrast, Table 3 for the studies that actually contributed to these clusters). We did not find significant results in the meta-analyses for any other contrast (Table 4 gives an overview of the peak p values of all contrasts).
To gain insight into possible biological relationships between the seven implicated genes, we mapped six of them to 266 GO terms of the category "biological process" (AKT1, CNNM2, DISC1, DTNBP1, VAV3), then five to 59 "cellular component" terms (AKT1, CNNM2, DISC1, DTNBP1, VAV3), and three to 17 "molecular function" terms (AKT1, VAV3, ZNF804A); CCDC68 was not mapped to any category due to missing data in the bioinformatic resource that we used. To reduce the redundancy among the mapped data, we performed clustering analyses and found representative, non-redundant subsets of semantically similar terms; this procedure was done for each category separately. For "biological process", we identified 154 cluster representatives, 40 for "cellular component", and 16 for "molecular function" (Supplementary Table 3 ).
Analyses according to gene ontology
To achieve a data-driven grouping for the coordinate-based meta-analyses, we mapped the 26 genes from the selected literature to GO functional categories and performed a GSEA in each category. We found the terms "axon", "cellular projection", "neuron part" and "neuron projection".
Overall, we did not observe any significant result in the coordinate-based meta-analyses that were informed by GO.
Conjunction analysis between the genotype × diagnosis finding and structural changes in schizophrenia
There was no spatial overlap between our present findings and the clusters that have been identified by our previous meta-analysis on brain structure changes in schizophrenia (Nickl-Jockschat et al. 2011) . Coordinates that contributed to the cluster in the left middle temporal gyrus stemmed from contrasts of studies investigating genetic variants in the following genes: ZNF804A (rs1344706), CNNM2 (rs7914558), AKT1 (rs2494732) and DTNBP1 (rs1011313). For the cluster in the right supramarginal gyrus, we found coordinates contributing that investigated variants in the following genes: VAV3 (rs1410403), CCDC68 (rs12966547) and DISC1 (rs821597). For statistical inference, the ensuing statistical parametric maps stemming from our ALE analysis were thresholded at p < 0.05 (cluster-level FWE, corrected for multiple comparisons, cluster-forming threshold at voxel level p < 0.001; Turkeltaub et al. 2012) 
Discussion
Imaging genetic approaches have been discussed critically, since candidate gene associations with brain function have generally not been confirmed in meta-analyses (Poldrack and Farah 2015) . The lack of significant findings in our main meta-analysis and most of our subanalyses are well in accordance with this notion.
It deserves to be emphasized that we only retrieved significant results, when we pooled over studies analyzing gene × diagnosis interactions, while other groupings, e.g., based on biological information about the implicated genes (GO terms) did not yield any significant convergence of findings. The latter finding appears as contradictory to the prevalent notion in the field that research approaches based on biological (patho-)mechanisms might help to reduce the heterogeneity of imaging findings compared to a purely symptom-based definition of schizophrenia (Tandon et al. 2013; Gur et al. 2007 ).
Methodological considerations
There are several caveats that limit the interpretation of our results. First, our approach quantitatively summarizes the findings of structural imaging studies across susceptibility gene variants. While we purposefully aimed to include all variants that were described by the authors of the respective study themselves as associated with schizophrenia to avoid an early selection bias, our data pool is certainly limited to the published literature. Consequently, a GWAS that Table 2 Overview of all studies analyzed with gene × diagnosis contrasts that were analyzed in our meta-analysis, including the studied SNPs, the genes that these SNPs map to, the diagnoses and the diagnostic criteria used (if available) does not entail such limitation might yield different results regarding a potential homogenization of study findings on structural changes due to biological pathways. Second, we here utilized an observer-independent approach for a grouping of studies due to biological mechanisms, including a network analysis of the protein encoding genes and a subsequent enrichment analysis available through STRING v10 (Szklarczyk et al. 2015) . This approach yields the great advantage of a systematic datadriven grouping, but is certainly limited by the current characterization of the respective gene products. This is especially important with regard to genes identified by actual GWAS approaches (Schizophrenia Working Group of the Psychiatric Genomics consortium 2014) that have attracted increased attention only recently after their identification, rendering their biological functions often as comparatively sparsely understood. Thus, our GO term analysis might favor an enrichment of longer known and, therefore, better characterized genes, despite lesser evidence for their association with schizophrenia. Moreover, many classical candidate genes were not found to be associated with schizophrenia by GWAS, which may create more biological heterogeneity. This may distort the results of our subsequent ALE analysis.
Third, the number of studies enrolled in the genotype × diagnosis is rather low (n = 15). While certainly a higher number of contributing studies would be desirable (Eickhoff et al. 2016) , it should be emphasized that ALEbased meta-analyses yielded significant and robust results enrolling even smaller numbers of studies (Nickl-Jockschat et al. 2015a, b) .
While ALE is a well validated and widely used coordinate-based meta-analytic approach ), a mega-analysis pooling over original imaging data sets may have most likely provided a greater sensitivity. However, it should also be noted that this advantage of a mega-analysis would have come at the prize of a limited generalization, since it would not pool across different analysis approaches.
Given our inclusion and exclusion criteria, we had to exclude a large number of the initially screened publications. The most common reasons, besides not reporting original findings, for this are the lack of appropriate contrasts, the fact that the respective studies did not use whole-brain analyses and missing standard-space coordinates for the observed findings. Options to utilize at least a subset of those studies for confirmatory purposes appear as highly warranted. Unfortunately, however, exactly those reasons that led to an exclusion of the experiment in the first place also hinder their use for validation. In this context, we would like to point out, in particular, that ALE relies upon the use of unrestricted (=whole-brain) inference spaces. This is due to the fact that any exclusion of given brain regions would unavoidably lead to a spatial bias and distort the results of the meta-analysis accordingly. While ROI-based original studies and, hence, respective meta-analyses of these, in turn, have the advantages of an increased sensitivity for subtle changes of structure and function within the studied brain region, it deserves to be emphasized that ROI-and coordinate-based meta-analyses are based upon different, and partially antithetic, conceptual assumptions that severely hamper their comparability. Consequently, although a broader utilization of the initially identified studies would appear as desirable, current methodological limitations do not allow that.
As noted, ALE is a powerful tool to determine whether results of original neuroimaging studies spatially converge above chance. Obviously, however, this information would be ideally supplemented by inference on effect sizes and publication bias, but standard, validated tools for such purposes are still missing. In addition, we note that effect sizes are rarely and heterogeneously reported in the neuroimaging literature and, if provided, be strongly biased of computed at the peak voxel of a previous statistical inference.
Moreover, to avoid subjective selection biases, we have pooled over all studies on genetic variants that were classified by the authors of the respective original studies as associated with schizophrenia. Given the recent progress in this field, it stands to reason that a meta-analysis on studies analyzing only variants with GWAS evidence might be a very promising approach. Such an approach would also allow to differentiate between protective and risk alleles and offer the option of respective subanalyses. However, the number of imaging genetic studies on GWAS variants is insufficient up to now to allow a robust analysis. Important insights into the pathogenesis of brain structure changes in schizophrenia can be expected, once a sufficiently high number of studies are available.
Finally, we have realized cluster-level corrections for multiple comparisons within a given sub-analysis, but in line with the current standards for neuroimaging in general and coordinate-based meta-analyses especially, we did not additionally correct for the number of (sub-)analyses that were conducted (Goodkind et al. 2015; Nickl-Jockschat et al. 2015a, b) .
Grouping of studies due to gene × diagnosis interactions, not biological information, leads to significant results
Diagnostic schemes based solely on a constellation of symptoms have been criticized because of their poor reliability in clinical settings (Miller et al. 2001) , their instability over the course of time and their low specificity (summarized in Tandon et al. 2013 ). The are two major diagnostic systems used today, ICD-10 and DSM-V; however, both base their diagnostic criteria for schizophrenia on a catalogue of symptoms and demand that a certain number out of this pool must to be present over a given period of time. It seems proximate that this syndromal definition might create a significant biological heterogeneity. In other words, the concept of schizophrenia might serve only as an umbrella that envelopes a group of etiologically and pathophysiologically heterogeneous disorders. Correspondingly, the frequent finding of a greater heterogeneity within patient groups compared to healthy controls by neuroimaging studies has been interpreted as indicator that different endophenotypes are all subsumed under the label of schizophrenia (Gur et al. 2007; Tandon et al. 2013 ). This has led researchers to question the validity of the concept of schizophrenia and raised the demand to move research away from cohorts defined by diagnostic criteria towards dimensions based on clinical phenomenology and putative biological underpinnings.
Imaging genetic approaches have been proposed to delineate distinct endophenotypes and, thus, reduce heterogeneity within the patient group (cf. Thompson et al. 2014) . While certainly a deconstruction of schizophrenia itself is not possible by our approach, it does allow proxy conclusions, whether a grouping of imaging genetics studies along biological criteria helps to increase the likelihood of convergent findings. An increased likelihood of convergent findings under these conditions, in turn, would be an indicator for distinct endophenotypes.
We here capitalized on the richness of the imaging genetics literature to meta-analytically compare the spatial convergence of findings reported by original studies after grouping them according to biological mechanisms or primarily non-biologically derived criteria. Given the above-mentioned considerations, we hypothesized that a grouping by biological mechanisms would lead to a stronger convergence of results than those based on other criteria. To our surprise, we found significant results only in our meta-analysis on studies reporting on genotype × diagnosis interactions, while the grouping of studies based on biological mechanisms did not yield any significant results.
Given these findings, schizophrenia as defined by today's classification systems might be biologically a more homogeneous entity than the currently prevalent notion indicates. Interactions between genetic risk variants and general disease processes could play a decisive role in the actual manifestation of brain structure changes, while the effects of genetic risk variants in healthy subjects might only exert minor effects. This idea of a critical effect of the manifestation of disease on genotype effects is supported by the time course of brain structure changes before and after the onset of schizophrenia. Although mild differences in brain structure between asymptomatic subjects at high risk for psychosis and typical controls can be observed, it is transition to psychosis that goes along with pronounced changes in brain structure, especially with volume loss in frontal and temporal brain region (Fusar-Poli et al. 2012) . Also after the manifestation of the disorder, structural pathologies remain progressive, especially during the first year (Andreasen et al. 2011) , and are associated with psychopathological dimensions (Ho et al. 2003) . These progressive brain structure changes, obviously closely linked to the onset and/or worsening of symptoms, indicate that disease-associated processes are important modulators of brain structure changes in schizophrenia patients. According to our results, this modulator might play a crucial role in mediating effects of gene variants on brain structure. The finding that grouping according to diagnostic status indeed leads to significant results, while a sorting by biological mechanisms fails to do so, could be a valid indicator that-despite the common notion-the diagnostic criteria for schizophrenia create a neurobiologically comparatively homogeneous group of patients, at least with regard to brain structure changes.
Analysis of studies on gene × diagnosis interactions reveals a fronto-temporal pattern of brain structure changes
The larger cluster that we retrieved for our genotype × diagnosis meta-analysis was located in the left middle temporal gyrus. Analysis by cytoarchitectural probabilistic mapping referred the changes to be mainly located in TE1.0, partially extending into TE1.2, both being cytoarchitectonic subdivisions of the primary auditory cortex (Morosan et al. 2001) . Auditory hallucinations are a hallmark in schizophrenia symptomatology and have been highlighted as a key symptom of the disorder in the literature early on (Schneider 1950) . Functional imaging studies have pinpointed the primary auditory cortex as one of the hubs involved in the pathogenesis of auditory hallucinations (Jardri et al. 2011) . Concordant with these findings, on a structural level, also schizophrenia patients with auditory hallucinations showed convergent evidence for grey matter atrophy in the primary auditory cortex (Modinos et al. 2013) . Our finding of convergent brain structure changes associated with schizophrenia risk variants in the primary auditory cortex provides a potential explanatory model for the influence of genetic factors on this brain region that is a pivotal intersection in the pathophysiology of auditory hallucinations.
Previous findings hint at an association between volume changes of the orbitofrontal cortex and cognitive deficits (Nakamura et al. 2008 ). Complementary to this, also abnormal structural connectivity has been linked to impaired cognitive functioning in schizophrenia patient (James et al. 2016) . Cognitive functioning in schizophrenia patients, in turn, has been shown to be amongst the symptom domains with the highest heritability for this disorder (van Os et al. 2010) . The results of our study suggest that the orbitofrontal cortex might be a critical hub, in which genetic variants might exert an influence on psychopathological dimensions, namely cognitive functioning, by modulating brain structure.
Remarkably, the clusters retrieved from our analysis showed no overlap with regions that were consistently structurally altered in schizophrenia patients (Nickl-Jockschat et al. 2011) . This finding seems to be counterintuitive at first, though, might be potentially explained by the fact that the structural endophenotype of schizophrenia that we used here in our analysis was derived from a previous metaanalysis. Meta-analyses have the potential to determine the "smallest common denominator" of findings that converge across studies. However, they certainly only have a limited potential to capture interindividual variances. With regard to schizophrenia, interindividual variances have been linked to different clinical presentations. Grey matter reductions, e.g., in various regions of the right lateral temporal lobe and in the right anterior cingulate cortex have been reported to be associated with increased symptom severity in psychopathological dimensions, such as formal thought disorder and paranoia (Lui et al. 2009 ). In another sample, a correlation between grey matter volume and working memory performance was found in schizophrenia patients (Zierhut et al. 2013) . Bodnar et al. (2014) also hint at an association between reduced cortical thickness of the right temporoparietal junction and persisting negative symptoms. It should be noted that all these regions implicated in psychopathological variance are situated outside the network we found to be altered in our study on brain structure changes in schizophrenia (Nickl-Jockschat et al. 2011) . Following this line of thought, the genes contributing to the clusters found by our analysis might contribute to the manifestation of these interindividual differences of brain structural changes in schizophrenia patients.
Biological roles of the genes that contributed to the clusters found by our gene × diagnosis interaction analysis
We used post hoc bioinformatic analyses of the genes that contributed to the two clusters of our gene × diagnosis interactions analysis to reduce the redundancy among the GO terms for a better biological interpretation of this finding. Multiple GO terms that are representative for clusters of semantically similar terms highlight biological processes obviously involved in the central nervous system, especially the cluster representative "brain development" (GO:0007420) including proliferation and differentiation of neuronal cells and formation of macro-anatomical structures such as forebrain, pallium and telencephalon (AKT1, DTNBP1, VAV3, DISC1) Xu et al. 2015; Aleksic et al. 2013; Johnstone et al. 2011) . Further aspects at the cellular and tissue level of the brain are accentuated through cluster representatives such as "gliogenesis" (GO:0042063; AKT1, DISC1) (Lee et al. 2010; Wang et al. 2016 ), "Schwann cell differentiation" (GO:0014037; AKT1) (Taveggia et al. 2010) and "anatomical structure formation involved in morphogenesis" (GO:0048646) that emphasizes axon guidance (DISC1, DTNBP1, VAV3) (Kvajo et al. 2011; Lee et al. 2015; Cowan et al. 2005) .
Many representatives belong to neurotransmission and signaling pathways strongly discussed in the context of schizophrenia, of note, "regulation of dopamine receptor signaling pathway" (GO:0060159; DTNBP1) (Papaleo and Weinberger 2011) , "G protein-coupled receptor signaling pathway" (GO:0007186; AKT1) (New et al. 2007 ), "canonical Wnt signaling pathway" (GO:0060070; DISC1) (Salinas 2012) , "TOR signaling" (GO:0031929; DISC1) (New et al. 2007) , and "regulation of kinase activity including JNK and JUN" (GO:0043549; AKT1, DTNBP1, VAV3) (Kim et al. 2002; Tohyama et al. 2015) . The representative term "positive regulation of lymphocyte activation" (GO:0051251; AKT1, VAV3) (Bitanihirwe et al. 2010; Inabe et al. 2002) stresses a role of the immune system in disease etiology. The representative "metal ion binding" (GO:0046872) addresses the molecular function of the transcription factor ZNF804A to form a complex with Zn 2+ ions for binding to DNA. A recent study has provided strong evidence that ZNF804A regulates the expression of four schizophrenia-associated genes of which two (COMT, DRD2) have been contributed to our gene × diagnosis interaction finding (Girgenti et al. 2012) . Moreover, ZNF804A is the only of the seven genes that harbor a SNP showing genome-wide significant association with schizophrenia (Schizophrenia Working Group of the Psychiatric Genomics consortium 2014).
Conclusions
We here have demonstrated that a large-scale coordinatebased meta-analysis can be meaningfully used to synthesize findings of structural imaging genetic studies pooling over different schizophrenia susceptibility variants. It deserves to be emphasized that the large majority of our contrasts, including the main contrast pooling over all studies, did not yield significant results. This lack of significant findings for most contrasts applied should urge a more cautious interpretation of the results of individual imaging genetic studies. Despite this majority of negative findings, remarkably, we found a significant convergence of results for studies analyzing genotype × diagnosis interactions in the left middle temporal gyrus and the right gyrus rectus close to the midline, both regions that have been implicated previously by studies as potentially involved in the pathophysiology of schizophrenia. This is the first meta-analytical evidence for a convergence of results in imaging genetics. Finally, our data provide first hints that schizophrenia as defined by might be a more homogeneous and biologically valid entity than commonly perceived.
